You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A cloud-based WGS platform for establishing phylogeny within epidemic outbreaks at hospitals
SBC: ICBiome Topic: NIAIDOutbreaks have become a significant public threat in hospitalsimpacting both patient lives and creating a financial burdenWith the increasing rise in antibiotic resistancenew interventions are urgently needed to contain ongoing outbreaksRecent studies have confirmed that whole genome sequencingWGSis able to identity unique mutations within each outbreak strainwhich can then be utilized to establis ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
AmplideX DeepNet, a new paradigm for deep learning analytical tools in the molecular diagnostic space
SBC: ASURAGEN, INC. Topic: 400Project SummaryAn extensible analysis platform will be developed to accurately perform the automated genotyping of PCR capillary electrophoresisCEtraces for multiple disease associated short tandem repeaterSTRassaysThis study will evaluate the feasibility of developing generalizable and adaptive molecular analysis modelsand will ultimately establish a new paradigm for deep learning analytical tool ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Rapid electrochemical detection of arsenic in water
SBC: LYNNTECH INC. Topic: NIEHSPROJECT SUMMARYArsenic in drinking water poses a serious health hazard to tens of millions of peopleespecially in parts of the world where the arsenic concentrations far exceed theppb guideline value set by the World Health OrganizationAccording to a recent studyapproximatelyM people in the conterminous U Suse water from domestic wellsmillion out of themillion peopleare predicted to be using wells ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
A novel antibody therapy for Sin Nombre virus infection
SBC: CELDARA MEDICAL, LLC Topic: NIAIDProject Summary Rodent-borne viral outbreaks are increasing in both frequency and impact. Hantaviruses are transmitted through the excreta of infected rodents and, when aerosolized, infect humans. In the Americas, hantavirus infection leads to hantavirus cardiopulmonary syndrome (HCPS), a devastating condition that features rapid onset of pulmonary edema, respiratory failure and cardiogenic shock. ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
An Interactive, Patient-Specific Virtual Surgical Planning System for Upper Airway Obstruction Treatments
SBC: KITWARE INC Topic: NIBIBABSTRACTUpper airway surgery encompasses a group of procedures commonly used to treat upper airway obstructionincluding maxillomandibular advancementsurgery of the soft palatenasal surgerytongue reduction surgeryand correction of tracheal stenosisCurrent diagnosis and the subsequent decision making of these pathologies primarily rely on the clinical examination and objective measures such as acous ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
A high-throughput cell-free profiling platform integrating high metabolic diversity for chemical safety assessment
SBC: ZYMTRONIX CATALYTIC SYSTEMS, INC. Topic: NIEHSAbstract Roughlynew drugs and chemicals are commercialized each year successfully clearing research and developmentRandamp Dhurdles to meet the safety requirements of regulators such as the U SFood and Drug AdministrationThese successeshoweverare the exception rather than the rule making it advantageous for Randamp D programs to have methods in place that ensure unsafe compoundsfail fastwell befor ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma
SBC: Curebiotech, Inc. Topic: 102PROJECT SUMMARY Malignant melanoma is one of the most aggressive types of skin cancer, causing a large majority of skin-cancer related deaths worldwide. The combination of anti-PD-1 and anti-CTLA-4 is FDA approved for metastatic melanoma and shows better efficacy than any single agent alone. Unfortunately, the incidence of high-gr ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Analytics-Based Platform for Diabetic Retinopathy Care Management
SBC: RETINAL CARE INC Topic: NEIABSTRACT Despite the overefficacy of diabetic retinopathyDRtreatmentit continues to be the leading cause of blindness in working age AmericansOvermillion adults in the US have diabetesOf thesewill develop DR andwill develop vision threatening DRVTDRCurrentlyless than half of all patients with diabetes receive the recommended annual dilated eye exam andof those diagnosed with VTDRonlyundergo timely ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Rat Germline Gene Editing Products and Services
SBC: GenomeDesigns Laboratory LLC Topic: NIDASummary Rat research models are established to investigate a broad spectrum of human health issues significant to most NIH Institutes and are reported in andgt;1.5 million publications listed on NCBI PubMed Central. Direct germline editing products and services generated by this SBIR project will streamline production of the most sophisticated, genetically designed rat models used to study gene, c ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
MicroRNA-based Diagnostic Biomarker for Pulmonary Hypertension
SBC: MIRNA ANALYTICS LLC Topic: NHLBIAbstract Mirna Analytics is proposing to develop a microRNAmiRNAmarker for pulmonary hypertensionThis proposal is focused on the identification of optimal miRNAandapos s to form composite markers that can be measured in the serum plasmaPulmonary hypertensionan excessive increase of the pressure in the pulmonary circulationcan be due to many different reasonsPulmonary hypertension can be a deadly d ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health